Novel insulins: expanding options in diabetes management
- 1 September 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (4) , 308-316
- https://doi.org/10.1016/s0002-9343(02)01176-2
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Physiological insulin replacement in type 1 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2001
- Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.Diabetes Care, 2000
- Improved mealtime treatment of diabetes mellitus using an insulin analogueClinical Therapeutics, 1997
- Insulin analoguesPostgraduate Medicine, 1997
- Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular InsulinDiabetes Care, 1996
- Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodesExperimental and Clinical Endocrinology & Diabetes, 1996
- Preparation of an Insulin with Improved Pharmacokinetics Relative to Human Insulin through Consideration of Structural Homology with Insulin-Like Growth Factor IHormone Research, 1994
- The Importance of the Time Interval Between Insulin Injection and Breakfast in Determining Postprandial Glycaemic Control-A Comparison Between Human and Porcine InsulinDiabetic Medicine, 1988
- Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes MellitusDiabetes Care, 1983
- Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin TherapyNew England Journal of Medicine, 1980